Compare WS & ALMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WS | ALMR |
|---|---|---|
| Founded | 1955 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Laboratory Analytical Instruments |
| Sector | | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2023 | 2026 |
| Metric | WS | ALMR |
|---|---|---|
| Price | $37.76 | $36.57 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $42.50 | N/A |
| AVG Volume (30 Days) | ★ 200.4K | 197.9K |
| Earning Date | 03-25-2026 | N/A |
| Dividend Yield | ★ 1.76% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.17 | N/A |
| Revenue | ★ $3,443,800,000.00 | N/A |
| Revenue This Year | $16.77 | N/A |
| Revenue Next Year | $2.69 | N/A |
| P/E Ratio | $224.59 | ★ N/A |
| Revenue Growth | ★ 11.33 | N/A |
| 52 Week Low | $27.22 | $21.58 |
| 52 Week High | $49.17 | $29.43 |
| Indicator | WS | ALMR |
|---|---|---|
| Relative Strength Index (RSI) | 58.21 | 80.91 |
| Support Level | $38.01 | $23.69 |
| Resistance Level | $39.02 | N/A |
| Average True Range (ATR) | 1.79 | 2.23 |
| MACD | 0.36 | 0.83 |
| Stochastic Oscillator | 79.72 | 98.37 |
Worthington Steel Inc is a processor of carbon flat-rolled steel, a producer of laser-welded solutions, and a provider of electrical steel laminations. The company has manufacturing facilities across the United States, Canada, China, India, Germany and Mexico. It buys coils of steel from primary steel producers and processes them to precise type, thickness, length, width, shape, and surface quality required by customer specifications. The company's product lines and processing capabilities include; carbon flat-rolled steel processing, electrical steel laminations, and tailor welded products. Geographically, the company generates a majority of its revenue from the United States followed by Canada, Mexico, and other regions.
Alamar Biosciences Inc is a proteomics company engaged in protein detection and analysis. The company has developed its own NULISA (NUcleic Acid Linked Immuno-Sandwich Assay) technology as the foundation of its Precision Proteomics platform enabling the detection and quantification of protein biomarkers in a single sample with ultra-high sensitivity and high specificity, even from very small volumes of biofluid. The company operates in single segment and focuses on developing a good sensitive proteomic liquid biopsy platform and sells instruments, consumables, and services based on this platform to enable early detection of diseases. The products of the company includes NULISAseq Panels, NULISAqpcr Assays, and others.